The quality of swallowing for patients with operable esophageal carcinoma : A randomized trial comparing surgery with radiotherapy
β Scribed by Rajendra A. Badwe; Vinay Sharma; Mehul S. Bhansali; Ketayun A. Dinshaw; Prakash K. Patil; Neelima Dalvi; Srinivas G. Rayabhattanavar; Prafulla B. Desai
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 84 KB
- Volume
- 85
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Background:
Surgery is considered the standard treatment for operable esophageal carcinoma, although there is no compelling evidence that surgery can achieve better results than radiotherapy. there has previously been no direct randomized comparison of these two modalities with survival or disease specific outcome end points.
Methods:
Ninety-nine patients with operable squamous cell carcinoma of the esophagus were randomly allocated to surgery or radiotherapy after stratification for tumor length (< or = or >5 cm). those randomized to surgery underwent transthoracic esophagectomy with limited lymphadenectomy, whereas those in the radiotherapy arm received 50 gray in 28 fractions followed by a 15-gray boost to the primary tumor. disease specific outcome was assessed for 4 subgroups: 1) disease specific symptoms, 2) physical symptoms, 3) ability to work, and 4) social/family interaction and global perception of disease specific outcome. the questionnaire was given prior to treatment and posttreatment at 3-month intervals for 1 year. death was a secondary end point.
Results:
There was an overall improvement in the quality of swallowing in both treatment arms after treatment and with the passage of time. the swallowing status was better in the surgery arm than in the radiotherapy arm at 6 months after treatment (p = 0.03, fisher's exact test). logistic regression analysis showed randomization arm (p = 0.035), time since treatment (p = 0.003), and pretreatment swallowing status to be significant determinants of posttreatment swallowing status. surgery was twice as likely to result in improvement in swallowing than radiotherapy after correction for time and pretreatment swallowing status. overall survival was better in the surgery arm than in the radiotherapy arm (p = 0.002, log rank test) (or = 2.74 with 95% confidence intervals 1.51-4.98; p < 0.009, cox proportional hazards model).
Conclusions:
Both surgery and radiotherapy can improve the quality of swallowing significantly for patients with operable esophageal carcinoma. surgery is marginally superior to radiotherapy in improving the quality of swallowing. in this trial, survival in the surgery arm was significantly better than in the radiotherapy arm, although the small number of patients is a limitation.
π SIMILAR VOLUMES
## BACKGROUND. Although thoracic radiotherapy is considered to be useful for the treatment of patients with small cell lung carcinoma (SCLC), its optimal administration schedule is still controversial. ## METHODS. In a multicenter clinical trial, 164 patients with limited SCLC (of whom 156 were e
## BACKGROUND. The aim of this trial was to compare the outcome achieved with neoadjuvant chemotherapy followed by radiotherapy to that achieved with radiotherapy alone for patients with locoregionally advanced undifferentiated or poorly differentiated nasopharyngeal carcinoma (NPC) meeting one of
## BACKGROUND. The use of adjuvant tamoxifen to treat postmenopausal breast carcinoma patients as an adjunct to primary surgery is well established. The current study reports the long term results for a low risk stratum in a randomized trial of adjuvant tamoxifen. The main focus of this analysis w
The current study presents mature results from a Phase III randomized trial comparing radiation therapy and concurrent chemoradiotherapy in patients with resectable American Joint Committee on Cancer Stage III and IV disease.